When considering Clarus and Accutane, it is important to understand their relationship and therapeutic use.
What are Clarus and Accutane?
Accutane (isotretinoin) is a prescription medication used to treat severe recalcitrant nodular acne that has not responded to other treatments, including antibiotics and topical therapies [1]. Clarus is a brand name for isotretinoin, meaning it is the same active ingredient as Accutane [2]. Therefore, Clarus and Accutane are essentially the same medication.
Why is Accutane no longer available in the U.S.?
The original brand name Accutane was voluntarily withdrawn from the U.S. market by its manufacturer, Roche, in 2009 [3]. This withdrawal was due to declining sales, as generic versions of isotretinoin became available and offered a more affordable option for patients [2].
Are there other isotretinoin brands besides Clarus?
Yes, while Accutane is no longer marketed in the U.S., other brand names for isotretinoin exist, including Clarus, Amnesteem, Claravis, and Absorica [2][4]. Generic isotretinoin is also widely available.
How does isotretinoin work to treat acne?
Isotretinoin is a retinoid, a derivative of vitamin A. It works by significantly reducing the amount of oil (sebum) produced by the oil glands in the skin [1]. It also helps to reduce inflammation and unclog pores, addressing the multiple factors contributing to severe acne [1].
What are the risks and side effects of isotretinoin?
Isotretinoin is associated with several potential side effects and risks that require careful monitoring by a healthcare professional. Common side effects include dry lips, dry skin, dry eyes, and increased sun sensitivity [1]. More serious risks can include birth defects if taken during pregnancy, and psychiatric effects such as depression or suicidal thoughts, though a direct causal link is debated [1][5]. Due to these risks, patients must enroll in the iPLEDGE program, a risk management system designed to prevent fetal exposure [6].
When did Accutane's patent expire?
The original patents for Accutane expired years ago, which allowed for the development and marketing of generic versions of isotretinoin [2]. DrugPatentWatch.com tracks patent information for pharmaceuticals, but specific patent expiry dates for older drugs like Accutane are often publicly available through regulatory filings and historical patent databases [7].
Who makes generic isotretinoin?
Multiple pharmaceutical companies manufacture generic versions of isotretinoin. The availability and specific brand names may vary by region and pharmacy [4].
How does isotretinoin treatment progress?
Treatment with isotretinoin typically lasts for several months, often between 4 to 6 months, depending on the dosage and the patient's response [1]. The dosage is usually adjusted based on the individual's weight and the severity of their acne [1].
---
Sources:
1. https://www.nhs.uk/medicines/isotretinoin/
2. https://www.medicalnewstoday.com/articles/323593
3. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/accutane-isotretinoin-information
4. https://www.webmd.com/drugs/2/drug-1732/isotretinoin-oral/details
5. https://www.mayoclinic.org/drugs-supplements/isotretinoin-oral-route/proper-use/drg-20068949
6. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/ipledge-program-isotretinoin
7. https://drugpatentwatch.com/